Holdings (Monthly)
Guide ↗
State Street(R) SPDR(R) S&P(R) Biotech ETF
· Spdr Series Trust| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors | 857492706 | Mar 2026 | 595,460,501 | $595.5M | 8.01% | STIV |
| 2 | Apellis Pharmaceuticals Inc | 03753U106 | Mar 2026 | 3,390,454 | $136.4M | 1.83% | EC |
| 3 | Alkermes PLC | 000000000 | Mar 2026 | 3,050,830 | $107.9M | 1.45% | EC |
| 4 | Madrigal Pharmaceuticals Inc | 558868105 | Mar 2026 | 196,408 | $102.8M | 1.38% | EC |
| 5 | TG Therapeutics Inc | 88322Q108 | Mar 2026 | 3,020,301 | $100.3M | 1.35% | EC |
| 6 | Insmed Inc | 457669307 | Mar 2026 | 607,845 | $99.4M | 1.34% | EC |
| 7 | Scholar Rock Holding Corp | 80706P103 | Mar 2026 | 1,961,965 | $96.5M | 1.30% | EC |
| 8 | Apogee Therapeutics Inc | 03770N101 | Mar 2026 | 1,134,394 | $95.5M | 1.28% | EC |
| 9 | Protagonist Therapeutics Inc | 74366E102 | Mar 2026 | 878,071 | $92.5M | 1.24% | EC |
| 10 | Summit Therapeutics Inc | 86627T108 | Mar 2026 | 4,866,448 | $92.3M | 1.24% | EC |
| 11 | United Therapeutics Corp | 91307C102 | Mar 2026 | 155,530 | $92.2M | 1.24% | EC |
| 12 | Praxis Precision Medicines Inc | 74006W207 | Mar 2026 | 285,252 | $91.9M | 1.24% | EC |
| 13 | Arrowhead Pharmaceuticals Inc | 04280A100 | Mar 2026 | 1,458,207 | $91.4M | 1.23% | EC |
| 14 | Cogent Biosciences Inc | 19240Q201 | Mar 2026 | 2,348,101 | $90.4M | 1.22% | EC |
| 15 | Bridgebio Pharma Inc | 10806X102 | Mar 2026 | 1,186,816 | $88.1M | 1.19% | EC |
| 16 | PTC Therapeutics Inc | 69366J200 | Mar 2026 | 1,290,071 | $87.9M | 1.18% | EC |
| 17 | Cytokinetics Inc | 23282W605 | Mar 2026 | 1,331,453 | $87.8M | 1.18% | EC |
| 18 | Alnylam Pharmaceuticals Inc | 02043Q107 | Mar 2026 | 264,406 | $87.5M | 1.18% | EC |
| 19 | Exelixis Inc | 30161Q104 | Mar 2026 | 2,029,215 | $87.0M | 1.17% | EC |
| 20 | Nuvalent Inc | 670703107 | Mar 2026 | 846,768 | $86.8M | 1.17% | EC |
| 21 | Kymera Therapeutics Inc | 501575104 | Mar 2026 | 1,039,280 | $86.6M | 1.16% | EC |
| 22 | CG oncology Inc | 156944100 | Mar 2026 | 1,276,920 | $86.4M | 1.16% | EC |
| 23 | Natera Inc | 632307104 | Mar 2026 | 430,933 | $86.2M | 1.16% | EC |
| 24 | Neurocrine Biosciences Inc | 64125C109 | Mar 2026 | 654,044 | $86.2M | 1.16% | EC |
| 25 | Twist Bioscience Corp | 90184D100 | Mar 2026 | 1,808,036 | $85.9M | 1.16% | EC |
| 26 | Krystal Biotech Inc | 501147102 | Mar 2026 | 332,277 | $85.8M | 1.15% | EC |
| 27 | Vaxcyte Inc | 92243G108 | Mar 2026 | 1,472,715 | $85.6M | 1.15% | EC |
| 28 | Mirum Pharmaceuticals Inc | 604749101 | Mar 2026 | 923,473 | $85.3M | 1.15% | EC |
| 29 | Amicus Therapeutics Inc | 03152W109 | Mar 2026 | 5,895,670 | $85.3M | 1.15% | EC |
| 30 | Ionis Pharmaceuticals Inc | 462222100 | Mar 2026 | 1,132,906 | $85.1M | 1.14% | EC |
| 31 | Travere Therapeutics Inc | 89422G107 | Mar 2026 | 2,863,192 | $85.1M | 1.14% | EC |
| 32 | Arcellx Inc | 03940C100 | Mar 2026 | 740,785 | $85.1M | 1.14% | EC |
| 33 | Regeneron Pharmaceuticals Inc | 75886F107 | Mar 2026 | 109,400 | $84.5M | 1.14% | EC |
| 34 | Incyte Corp | 45337C102 | Mar 2026 | 895,013 | $84.2M | 1.13% | EC |
| 35 | Celcuity Inc | 15102K100 | Mar 2026 | 731,925 | $83.5M | 1.12% | EC |
| 36 | Revolution Medicines Inc | 76155X100 | Mar 2026 | 850,768 | $82.7M | 1.11% | EC |
| 37 | Halozyme Therapeutics Inc | 40637H109 | Mar 2026 | 1,274,489 | $82.4M | 1.11% | EC |
| 38 | Rhythm Pharmaceuticals Inc | 76243J105 | Mar 2026 | 941,162 | $81.9M | 1.10% | EC |
| 39 | Biogen Inc | 09062X103 | Mar 2026 | 444,855 | $81.6M | 1.10% | EC |
| 40 | Arcutis Biotherapeutics Inc | 03969K108 | Mar 2026 | 3,437,805 | $81.0M | 1.09% | EC |
| 41 | AbbVie Inc | 00287Y109 | Mar 2026 | 372,103 | $80.9M | 1.09% | EC |
| 42 | Gilead Sciences Inc | 375558103 | Mar 2026 | 580,264 | $80.9M | 1.09% | EC |
| 43 | CRISPR Therapeutics AG | 000000000 | Mar 2026 | 1,696,801 | $80.7M | 1.09% | EC |
| 44 | BioMarin Pharmaceutical Inc | 09061G101 | Mar 2026 | 1,404,601 | $79.3M | 1.07% | EC |
| 45 | Roivant Sciences Ltd | 000000000 | Mar 2026 | 2,864,237 | $79.3M | 1.07% | EC |
| 46 | Amgen Inc | 031162100 | Mar 2026 | 224,546 | $79.0M | 1.06% | EC |
| 47 | ImmunityBio Inc | 45256X103 | Mar 2026 | 10,244,025 | $78.6M | 1.06% | EC |
| 48 | Beam Therapeutics Inc | 07373V105 | Mar 2026 | 3,248,626 | $77.4M | 1.04% | EC |
| 49 | Viking Therapeutics Inc | 92686J106 | Mar 2026 | 2,369,189 | $77.1M | 1.04% | EC |
| 50 | Vera Therapeutics Inc | 92337R101 | Mar 2026 | 1,912,054 | $76.9M | 1.03% | EC |
| 51 | Moderna Inc | 60770K107 | Mar 2026 | 1,513,720 | $76.9M | 1.03% | EC |
| 52 | Vertex Pharmaceuticals Inc | 92532F100 | Mar 2026 | 172,078 | $76.8M | 1.03% | EC |
| 53 | Erasca Inc | 29479A108 | Mar 2026 | 4,733,094 | $76.6M | 1.03% | EC |
| 54 | ACADIA Pharmaceuticals Inc | 004225108 | Mar 2026 | 3,412,655 | $76.0M | 1.02% | EC |
| 55 | Sarepta Therapeutics Inc | 803607100 | Mar 2026 | 3,057,030 | $66.5M | 0.89% | EC |
| 56 | Agios Pharmaceuticals Inc | 00847X104 | Mar 2026 | 1,930,324 | $65.3M | 0.88% | EC |
| 57 | Ultragenyx Pharmaceutical Inc | 90400D108 | Mar 2026 | 3,107,837 | $65.1M | 0.88% | EC |
| 58 | Disc Medicine Inc | 254604101 | Mar 2026 | 1,012,048 | $64.7M | 0.87% | EC |
| 59 | Immunome Inc | 45257U108 | Mar 2026 | 2,934,802 | $64.2M | 0.86% | EC |
| 60 | Immunovant Inc | 45258J102 | Mar 2026 | 2,566,528 | $63.8M | 0.86% | EC |
| 61 | BioCryst Pharmaceuticals Inc | 09058V103 | Mar 2026 | 6,655,054 | $63.4M | 0.85% | EC |
| 62 | Veracyte Inc | 92337F107 | Mar 2026 | 1,957,681 | $63.1M | 0.85% | EC |
| 63 | Dyne Therapeutics Inc | 26818M108 | Mar 2026 | 3,437,524 | $62.3M | 0.84% | EC |
| 64 | Catalyst Pharmaceuticals Inc | 14888U101 | Mar 2026 | 2,268,292 | $56.2M | 0.76% | EC |
| 65 | Syndax Pharmaceuticals Inc | 87164F105 | Mar 2026 | 2,343,191 | $54.7M | 0.74% | EC |
| 66 | Denali Therapeutics Inc | 24823R105 | Mar 2026 | 2,830,854 | $54.4M | 0.73% | EC |
| 67 | Ideaya Biosciences Inc | 45166A102 | Mar 2026 | 1,628,726 | $54.3M | 0.73% | EC |
| 68 | Spyre Therapeutics Inc | 00773J202 | Mar 2026 | 1,069,556 | $53.9M | 0.73% | EC |
| 69 | GRAIL Inc | 384747101 | Mar 2026 | 1,041,295 | $53.8M | 0.72% | EC |
| 70 | Viridian Therapeutics Inc | 92790C104 | Mar 2026 | 2,667,007 | $52.2M | 0.70% | EC |
| 71 | Recursion Pharmaceuticals Inc | 75629V104 | Mar 2026 | 16,732,511 | $51.4M | 0.69% | EC |
| 72 | Kodiak Sciences Inc | 50015M109 | Mar 2026 | 1,344,151 | $51.2M | 0.69% | EC |
| 73 | Soleno Therapeutics Inc | 834203309 | Mar 2026 | 1,496,078 | $50.1M | 0.67% | EC |
| 74 | Dianthus Therapeutics Inc | 252828108 | Mar 2026 | 586,673 | $49.2M | 0.66% | EC |
| 75 | Intellia Therapeutics Inc | 45826J105 | Mar 2026 | 3,753,333 | $48.1M | 0.65% | EC |
| 76 | Mineralys Therapeutics Inc | 603170101 | Mar 2026 | 1,773,248 | $48.0M | 0.65% | EC |
| 77 | Arcus Biosciences Inc | 03969F109 | Mar 2026 | 2,163,363 | $46.7M | 0.63% | EC |
| 78 | Ardelyx Inc | 039697107 | Mar 2026 | 7,664,448 | $45.9M | 0.62% | EC |
| 79 | ADMA Biologics Inc | 000899104 | Mar 2026 | 4,916,092 | $44.3M | 0.60% | EC |
| 80 | Nurix Therapeutics Inc | 67080M103 | Mar 2026 | 2,809,877 | $43.6M | 0.59% | EC |
| 81 | Tango Therapeutics Inc | 87583X109 | Mar 2026 | 1,972,571 | $41.3M | 0.56% | EC |
| 82 | Celldex Therapeutics Inc | 15117B202 | Mar 2026 | 1,222,480 | $38.8M | 0.52% | EC |
| 83 | Novavax Inc | 670002401 | Mar 2026 | 4,667,715 | $38.0M | 0.51% | EC |
| 84 | Oruka Therapeutics Inc | 687604108 | Mar 2026 | 761,033 | $37.3M | 0.50% | EC |
| 85 | Olema Pharmaceuticals Inc | 68062P106 | Mar 2026 | 2,471,879 | $36.9M | 0.50% | EC |
| 86 | Stoke Therapeutics Inc | 86150R107 | Mar 2026 | 1,125,672 | $36.7M | 0.49% | EC |
| 87 | Vericel Corp | 92346J108 | Mar 2026 | 1,116,252 | $35.9M | 0.48% | EC |
| 88 | Capricor Therapeutics Inc | 14070B309 | Mar 2026 | 1,171,894 | $35.6M | 0.48% | EC |
| 89 | Palvella Therapeutics Inc | 697947109 | Mar 2026 | 274,232 | $34.2M | 0.46% | EC |
| 90 | Biohaven Ltd | 000000000 | Mar 2026 | 3,844,682 | $32.5M | 0.44% | EC |
| 91 | Monte Rosa Therapeutics Inc | 61225M102 | Mar 2026 | 1,966,731 | $32.4M | 0.44% | EC |
| 92 | Corvus Pharmaceuticals Inc | 221015100 | Mar 2026 | 2,116,858 | $31.0M | 0.42% | EC |
| 93 | Iovance Biotherapeutics Inc | 462260100 | Mar 2026 | 8,139,873 | $28.6M | 0.38% | EC |
| 94 | AnaptysBio Inc | 032724106 | Mar 2026 | 512,175 | $28.4M | 0.38% | EC |
| 95 | Relay Therapeutics Inc | 75943R102 | Mar 2026 | 2,831,639 | $28.2M | 0.38% | EC |
| 96 | uniQure NV | 000000000 | Mar 2026 | 1,697,402 | $27.8M | 0.37% | EC |
| 97 | ORIC Pharmaceuticals Inc | 68622P109 | Mar 2026 | 2,171,512 | $27.5M | 0.37% | EC |
| 98 | MannKind Corp | 56400P706 | Mar 2026 | 10,933,657 | $26.8M | 0.36% | EC |
| 99 | CareDx Inc | 14167L103 | Mar 2026 | 1,480,419 | $25.7M | 0.35% | EC |
| 100 | Taysha Gene Therapies Inc | 877619106 | Mar 2026 | 5,638,911 | $25.2M | 0.34% | EC |
| 101 | Tyra Biosciences Inc | 90240B106 | Mar 2026 | 655,457 | $25.1M | 0.34% | EC |
| 102 | Geron Corp | 374163103 | Mar 2026 | 16,613,693 | $24.8M | 0.33% | EC |
| 103 | Day One Biopharmaceuticals Inc | 23954D109 | Mar 2026 | 1,113,401 | $23.9M | 0.32% | EC |
| 104 | Precigen Inc | 74017N105 | Mar 2026 | 6,004,794 | $23.2M | 0.31% | EC |
| 105 | Vir Biotechnology Inc | 92764N102 | Mar 2026 | 2,527,795 | $22.6M | 0.30% | EC |
| 106 | KalVista Pharmaceuticals Inc | 483497103 | Mar 2026 | 1,077,952 | $21.7M | 0.29% | EC |
| 107 | CytomX Therapeutics Inc | 23284F105 | Mar 2026 | 4,511,036 | $21.2M | 0.29% | EC |
| 108 | Annexon Inc | 03589W102 | Mar 2026 | 3,823,368 | $21.2M | 0.28% | EC |
| 109 | Kura Oncology Inc | 50127T109 | Mar 2026 | 2,523,230 | $20.5M | 0.28% | EC |
| 110 | Inhibrx Biosciences Inc | 45720N103 | Mar 2026 | 296,581 | $19.9M | 0.27% | EC |
| 111 | SELLAS Life Sciences Group Inc | 81642T209 | Mar 2026 | 4,689,810 | $19.8M | 0.27% | EC |
| 112 | Janux Therapeutics Inc | 47103J105 | Mar 2026 | 1,424,540 | $19.8M | 0.27% | EC |
| 113 | Compass Therapeutics Inc | 20454B104 | Mar 2026 | 3,684,989 | $19.5M | 0.26% | EC |
| 114 | Savara Inc | 805111101 | Mar 2026 | 3,554,970 | $19.4M | 0.26% | EC |
| 115 | Rigel Pharmaceuticals Inc | 766559702 | Mar 2026 | 708,776 | $19.2M | 0.26% | EC |
| 116 | Sana Biotechnology Inc | 799566104 | Mar 2026 | 6,650,475 | $19.2M | 0.26% | EC |
| 117 | Cullinan Therapeutics Inc | 230031106 | Mar 2026 | 1,307,461 | $18.6M | 0.25% | EC |
| 118 | ARS Pharmaceuticals Inc | 82835W108 | Mar 2026 | 2,213,506 | $17.8M | 0.24% | EC |
| 119 | Zenas Biopharma Inc | 98937L105 | Mar 2026 | 906,255 | $17.7M | 0.24% | EC |
| 120 | Xencor Inc | 98401F105 | Mar 2026 | 1,422,163 | $17.2M | 0.23% | EC |
| 121 | Replimune Group Inc | 76029N106 | Mar 2026 | 2,198,386 | $16.8M | 0.23% | EC |
| 122 | Sionna Therapeutics Inc | 829401108 | Mar 2026 | 416,630 | $16.7M | 0.22% | EC |
| 123 | Vor BioPharma Inc | 929033207 | Mar 2026 | 932,400 | $16.6M | 0.22% | EC |
| 124 | ArriVent Biopharma Inc | 04272N102 | Mar 2026 | 701,088 | $16.2M | 0.22% | EC |
| 125 | Ironwood Pharmaceuticals Inc | 46333X108 | Mar 2026 | 3,999,224 | $14.0M | 0.19% | EC |
| 126 | Bicara Therapeutics Inc | 055477103 | Mar 2026 | 701,643 | $14.0M | 0.19% | EC |
| 127 | Prime Medicine Inc | 74168J101 | Mar 2026 | 3,979,993 | $13.9M | 0.19% | EC |
| 128 | Altimmune Inc | 02155H200 | Mar 2026 | 4,353,091 | $13.4M | 0.18% | EC |
| 129 | Absci Corp | 00091E109 | Mar 2026 | 4,448,453 | $13.3M | 0.18% | EC |
| 130 | Emergent BioSolutions Inc | 29089Q105 | Mar 2026 | 1,572,925 | $13.1M | 0.18% | EC |
| 131 | Allogene Therapeutics Inc | 019770106 | Mar 2026 | 5,212,606 | $12.7M | 0.17% | EC |
| 132 | Hyperliquid Strategies Inc | 44916Y106 | Mar 2026 | 2,451,336 | $12.5M | 0.17% | EC |
| 133 | 4D Molecular Therapeutics Inc | 35104E100 | Mar 2026 | 1,318,068 | $12.3M | 0.17% | EC |
| 134 | Vanda Pharmaceuticals Inc | 921659108 | Mar 2026 | 1,704,031 | $11.8M | 0.16% | EC |
| 135 | REGENXBIO Inc | 75901B107 | Mar 2026 | 1,363,810 | $11.4M | 0.15% | EC |
| 136 | Lexeo Therapeutics Inc | 52886X107 | Mar 2026 | 1,862,707 | $10.7M | 0.14% | EC |
| 137 | Verastem Inc | 92337C203 | Mar 2026 | 2,014,499 | $10.7M | 0.14% | EC |
| 138 | Arbutus Biopharma Corp | 03879J100 | Mar 2026 | 2,268,065 | $10.2M | 0.14% | EC |
| 139 | Myriad Genetics Inc | 62855J104 | Mar 2026 | 2,160,321 | $9.7M | 0.13% | EC |
| 140 | Prothena Corp PLC | 000000000 | Mar 2026 | 983,448 | $9.6M | 0.13% | EC |
| 141 | Ocugen Inc | 67577C105 | Mar 2026 | 5,222,819 | $9.5M | 0.13% | EC |
| 142 | Rocket Pharmaceuticals Inc | 77313F106 | Mar 2026 | 2,606,982 | $9.3M | 0.13% | EC |
| 143 | MiMedx Group Inc | 602496101 | Mar 2026 | 2,282,660 | $9.0M | 0.12% | EC |
| 144 | Akebia Therapeutics Inc | 00972D105 | Mar 2026 | 6,038,997 | $8.4M | 0.11% | EC |
| 145 | Anavex Life Sciences Corp | 032797300 | Mar 2026 | 2,653,883 | $8.1M | 0.11% | EC |
| 146 | CONTRA METSERA INC | 592CVR013 | Mar 2026 | 1,530,714 | $7.5M | 0.10% | DE |
| 147 | Invivyd Inc | 00534A102 | Mar 2026 | 5,654,625 | $7.4M | 0.10% | EC |
| 148 | Perspective Therapeutics Inc | 46489V302 | Mar 2026 | 1,713,495 | $7.1M | 0.10% | EC |
| 149 | State Street Global Advisors | 857492706 | Mar 2026 | 4,700,194 | $4.7M | 0.06% | STIV |
| 150 | Damora Therapeutics Inc | 36322Q206 | Mar 2026 | 93,797 | $2.4M | 0.03% | EC |
| 151 | CONTRA AKERO THERAPEUT | 009CVR044 | Mar 2026 | 2,033,975 | $1.3M | 0.02% | DE |
| 152 | CONTRA INHIBRX INC | 457CVR017 | Mar 2026 | 1,645,973 | $1.1M | 0.01% | DE |
| 153 | CONTRA MIRATI THERAPEU | 604CVR027 | Mar 2026 | 1,369,552 | $959K | 0.01% | DE |
| 154 | CONTRA VERVE THERAPEUT | 925CVR011 | Mar 2026 | 900,273 | $567K | 0.01% | DE |
| 155 | CONTRA BLUEPRINT MEDIC | 096CVR048 | Mar 2026 | 756,469 | $348K | 0.00% | DE |
| 156 | State Street Global Advisors | 857492706 | Mar 2026 | 36,551 | $37K | 0.00% | STIV |
| 157 | OMNIAB INC | 68218J202 | Mar 2026 | 161,959 | $0 | 0.00% | EC |
| 158 | OMNIAB INC | 68218J301 | Mar 2026 | 161,959 | $0 | 0.00% | EC |